Immatics presenting at Advanced Therapies Connect 2022
Jan 25 - Jan 28, 2022
Join Immatics at the Advanced Therapies Week, the destination for developers, investors and solution providers whose goal is to bring cell and gene therapies to patients.
Wednesday, January 26, 2:05pm - 2:20pm EST
Session: Managing a Robust Manufacturing and CMC Strategy to Avoid Regulatory Pitfalls
Presentation: Building A Manufacturing and Logistics Framework for TCR-Engineered Cell Therapies (TCR-T)
- Interconnected strategic aspects for autologous cell therapies
- Developing manufacturing and supply chain strategies for cell therapy products
- Outlook towards commercialization
Presenter: Pinar Cicalese, Director CMC Commercial Strategy, Immatics
Wednesday, January 26, 12:30pm - 13:30pm EST
Panel Discussion: Future-Proofing Cell Therapy Production
Speaker: Richard D Lopez, CEO and Founder, PhosphoGam; Mamta Kalra, Director CMC, Immatics; Matthew Li, Associate Director, Head of Cell Therapy Manufacturing Innovation; Alden Ladd, Associate Director, Cell and Gene Therapies, Beam Therapeutics
We are looking forward to (e-)meeting you!
For more information please visit the event's website.